Plus LibraryBy pinki@katapult.biz / February 13, 2025 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Clear Displaying 2,076 - 2,100 of 2,875 « 1 … 82 83 84 85 86 … 115 » Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy Surbhi Singhal, MD View Video Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy Surbhi Singhal, MD View PDF New Therapeutic Directions in Lung Cancer Surbhi Singhal, MD View PDF Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy Surbhi Singhal, MD View Video New Therapeutic Directions in Lung Cancer Surbhi Singhal, MD View Video 2024 Locally Advanced NSCLC Neoadjuvant/Adjuvant/Multi-Modality Sylvia Lee, MD View PDF 2024 Locally Advanced NSCLC Neoadjuvant/Adjuvant/Multi-Modality Sylvia Lee, MD View Video Lung Immunotherapy Tejas Patil, MD View Video Lung Immunotherapy Tejas Patil, MD View PDF Later lines of Treatment for NSCLC Tejas Patil, MD View PDF Later lines of Treatment for NSCLC Tejas Patil, MD View Video Tumor Biology, Pathology, Novel Diagnostics Tianhong “Tina” Li, MD, PhD View PDF Tumor Biology, Pathology, Novel Diagnostics Tianhong “Tina” Li, MD, PhD View Video Tumor Biology, Pathology, Novel Diagnostics Tianhong “Tina” Li, MD, PhD View Video Tumor Biology, Pathology, Novel Diagnostics Tianhong “Tina” Li, MD, PhD View PDF Tumor Biology, Pathology, Novel Diagnostics Tianhong “Tina” Li, MD, PhD View PDF Tumor Biology, Pathology, Novel Diagnostics Tianhong “Tina” Li, MD, PhD View Video Tumor Biology, Pathology, Novel Diagnostics Tianhong “Tina” Li, MD, PhD View PDF Tumor Biology, Pathology, Novel Diagnostics Tianhong “Tina” Li, MD, PhD View Video What After Immunotherapy Failure in First Line: Is There Hope? Ticiana A. Leal, MD View PDF What After Immunotherapy Failure in First Line: Is There Hope? Ticiana A. Leal, MD View Video Progress in Biomarkers for SCLC – Are We Ready for Implementation into Routine Clinical Practice? Ticiana Leal, MD View PDF Immunotherapy in Metastatic NSCLC: How to Choose Initial Therapy and What’s New? Tina Cascone, MD, PhD View PDF Other Driver Mutations in Lung Cancer - RET,ERBB2, MET, NTRK Tom Stinchcombe View PDF Moving the Bar Beyond PACIFIC. What is the Best Consolidation Therapy for People with Actionable and Non-Actionable Genes? Tom Stinchcombe, MD View PDF
